Hualan Biological Engineering
002007.SZ
#2887
Rank
HK$34.70 B
Marketcap
HK$18.98
Share price
2.53%
Change (1 day)
-21.10%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2024 (TTM): HK$1.89 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are HK$0.69 Billion. In 2023 the company made an earning of HK$2.27 Billion, an increase over its 2022 earnings that were of HK$1.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$1.89 B-16.79%
2023 HK$2.27 B39.21%
2022 HK$1.63 B-19.12%
2021 HK$2.02 B-17.9%
2020 HK$2.46 B37.11%
2019 HK$1.79 B11.71%
2018 HK$1.60 B50.84%
2017 HK$1.06 B1.1%
2016 HK$1.05 B23.49%
2015 HK$0.85 B8.37%
2014 HK$0.78 B10.83%
2013 HK$0.71 B54.56%
2012 HK$0.46 B-17.03%
2011 HK$0.55 B-41.34%
2010 HK$0.94 B6.15%
2009 HK$0.89 B261.3%
2008 HK$0.24 B85.75%
2007 HK$0.13 B49.27%
2006 HK$88.95 M56.98%
2005 HK$56.67 M34.28%
2004 HK$42.2 M